Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CD-34 Selection for Ex-vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts Receiving Intensive Conditioning

NCT00368355 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT00368355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00368355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CD-34 Selection for Ex-vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts Receiving Intensive Conditioning
Lead sponsor
Baylor College of Medicine
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2000
Completion date
November 30, 2016
Enrollment
46 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myeloid leukemia, chronic myelogenous leukemia, familial hemophagocytic lymphohistiocytosis (flh), hemophagocytic lymphohistiocytosis (hlh), myelodysplastic syndrome, non hodgkins lymphoma, viral-associated hemophagocytic syndrome (vahs), x-linked lymphoproliferative disease (xlp)